Abstract

One of the major public health issues that post-fistula patients face worldwide, particularly in sub-Saharan Africa, is a Urinary Tract Infection. Additionally, antimicrobial resistance hinders the effective treatment and prevention of ever-increasing bacterial infections. Post Fistula patients' antimicrobial susceptibility profiles and Urinary Tract infections were poorly documented. An abnormal opening that connects the vagina to another organ, like the bladder, rectum, or colon, is known as a Fistula. A severe medical condition in which a fistula (hole) forms between the vagina and the bladder (Vesicovaginal Fistula), the rectum and the vagina (Rectovaginal Fistula), the urethra and the vagina (Urethrovaginal Fistula), the colon and the vagina (Colovaginal Fistula), and the small intestine and the vagina (Colovaginal Fistula). Patients with fistulas are more likely to develop more severe UTIs if they receive prolonged hospitalization and more intensive care, such as Catheterization. If left untreated, UTIs can lead to serious complications like kidney damage, scarring, and renal failure. Proteus species, Klebsiella sp., Escherichia coli, Enterococcus, Pseudomonas aeruginosa, and UTIs are typically caused by Staphylococcus aureus the most prevalent bacteria.